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Insulin receptors are present on lymphoid cell lines  (1)  and activated murine and 
human lymphocytes (2,  3)  with similar physicochemical properties to those on liver 
cells and adipocytes. Resting small lymphocytes apparently lack specific binding sites 
for insulin  (2, 3), whereas they are present on mitogen-stimulated human (3) and rat 
(2) lymphocyte populations. Also, activated murine or human lymphocytes generated 
in mixed lymphocyte cultures express insulin receptors (4, 5). 
Our attention was drawn to the investigation of insulin receptors on T  lymphocytes 
by an intriguing report citing the insulin receptor as a  universal marker of activated 
lymphocytes (2). Because the above studies on lymphocyte insulin receptors have been 
done  on  heterogeneous  lymphocyte  populations,  it  was  of  interest  to  determine 
whether the insulin receptor is indeed expressed on all the various activated T  and B 
cell subsets, or rather on some but not others. If insulin receptors are expressed by a 
fraction of activated lymphocytes, can they be used as cell surface markers to define 
functional lymphocyte subpopulations or used as determinants of differentiation states 
of a  given lymphocyte lineage?  To investigate these  questions,  one can  fractionate 
splenic lymphocytes into subsets based on  cell surface markers  (e.g., Thy-1, Lyt-1, 
Lyt-2, surface immunoglobulin)  and  examine these  for insulin  receptor expression. 
Another possibility would be to examine cloned lymphocyte cell lines. 
We decided  to pursue the latter direction  using murine T  cell clones, which  are 
H-2 restricted, influenza virus specific and antigen dependent for proliferation (6, 7). 
We recently reported (6) the isolation, characterization, and continuous propagation 
of these cloned T  lymphocyte lines. The availability of these T  cell clones affords the 
opportunity  of examining  insulin  receptor  expression  on  homogeneous,  nontrans- 
formed cell lines with cytotoxic or helper function. Also, using a homogeneous T  cell 
clone, we can determine whether the insulin receptor can be a marker of the activated 
vs. the resting state of a given T  cell clone subsequent to antigenic stimulation. 
This report describes the expression of insulin receptors on noncytotoxic T  lympho- 
cyte clones  subsequent  to  specific  antigenic  stimulation  and  the  apparent  lack  of 
detectable insulin specific receptors on activated cytotoxic T  cell clones. 
Materials and Methods 
T  Cell Clones.  The isolation,  characterization, and propagation of cytotoxic T  cell clones 
14-1,  14-7, and  14-13 have been  previously described  (6). Cytotoxic T  cell  clone  23-9, of 
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(BALB/c X C57BL/6) FI (H-2  d'q') origin and H-2  a restricted in its recognition of A/Memphis/ 
1/71  influenza virus, was isolated and maintained in the same manner as the above cytotoxic 
T  lymphocytes (CTL) clones.  Non-CTL clones (22-2,  14-16, 28-3,  M3-2, M3-3) were isolated 
b/d  and maintained by the methods described for the CTL clones.  Clone 22-2 is of CB6F1 (H-2  ) 
origin  and  H-2 restricted,  A/MEM/71  specific.  Clone  14-16  is  of CB6F1  origin  and  H-2  d 
restricted in its recognition of A/JAP/57. Clone 28-3 is of BALB/cBy (H-2  a) origin and is H-2 
restricted and A/MEM/71  specific.  Clones M3-2 and M3-3 are BALB/cBy (H-2  a)  in origin 
and are specific for H-2I  b region molecules. Viable cloned T cells were separated from irradiated 
stimulator cells by centrifugation on Isopaque-Ficoll (8) before use in the insulin radioreceptor 
assay and indirect rosette assay.  (BALB/c ×  C57BL/6)F1, BALB/CByJ, C57BL/6J, CBA/J, 
and CBA/CaJ mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Influenza 
virus stocks were grown and stored as previously described (9). 
125I-Insulin Binding Assay.  Porcine insulin  and porcine proinsulin  were kindly supplied by 
Dr. R. Chance of Eli Lilly and Company, Indianapolis, IN. Desoctapeptide bovine insulin was 
a  gift  from  Dr.  H.  Carpenter.  Glucagon was  provided  by Dr.  R.  Gingerich  (Washington 
University,  St.  Louis,  MO)  and  human  growth  hormone was generously provided  by  the 
National Pituitary Agency (Baltimore, MD).  lzsI-insulin  was prepared at specific activities of 
100-200 #Ci using enzymo-beads from Bio-Rad Laboratories  (Richmond, CA) or a  soluble 
lactoperoxidase method (10). 
Cells (1-2 ×  107) were sedimented, medium aspirated, and pellets were resuspended in buffer 
containing 25 mM Tris, 120 mM NaCI, 1.2 mM MgSO4, 2.5 mM KC1, 10 mM glucose, 1 mM 
EDTA, and  1% bovine serum albumin, pH 7.8. Labeled hormone (10 -11 to 10  -1° M) and cells 
with and without increasing concentrations of unlabeled hormone were incubated for 90-120 
min at room temperature in 1.5 ml polypropylene tubes in a final volume of 0.5 ml. At the end 
of the incubation, tubes were centrifuged in a Beckman Microfuge (Beckman Instruments, Inc., 
Fullerton, CA) for 90 s. Supematants were aspirated, and pellets were washed with 0.4 ml of 
cold buffer. Cells were spun for an additional 30 s, supernatants aspirated, and pellets excised. 
Cell-associated radioactivity was counted in an autogamma counter. Data were analyzed by 
methods previously described (11). 
[3H]Thymidine  Incorporation.  Cellular proliferation was assessed  using a 4-h [aH]thymidine 
incorporation assay.  Quadruplicate  100-#1 cell culture samples  were delivered  to microtiter 
plate wells, and  100 #1 of [3H]TdR in phosphate-buffered saline (10 #Ci/ml) were added per 
well. Contents of wells were harvested onto glass fiber filters  using an automated cell harvester. 
Results are expressed as the mean counts per minute incorporated of the quadruplicates. 
Lyt  Phenotyping.  Viable  cloned  T  cells  were  incubated  with  monoclonal  anti-Lyt-1 
(53-7.313) or monoclonal anti-Lyt-2 (53-6.72)  antibodies and used in an indirect rosette assay, 
which has been described (6). 
Mixed Lymphocyte Culture.  Equal numbers of responder cells from CBA/CaJ mice (5 ×  107 
splenic lymphocytes) and irradiated  (2,000  rad)  stimulator cells  from CBA/J mice were co- 
cultured in Eagle's minimal essential medium containing 10% fetal bovine serum and 2 ×  10  -5 
M  2-mercaptoethanol and incubated at 37°C in a 7% COz/air atmosphere. 
Results 
To assess the role of the insulin receptor as a  marker for activated T  lymphocytes, 
we  examined  a  panel  of cytolytic  and  noncytolytic  murine  T  cell  clones  for  the 
expression  of insulin  receptors  2-4  d  after  antigenic  stimulation--the  peak  of the 
proliferative response.  The noncytolytic T  cell populations were either H-2I region- 
restricted,  influenza  virus-specific  clones  (22-2,  14-16,  28-3)  or  alloreactive  clones 
directed  to  H-2I  region  products  (M3-2,  M3-3).  These  T  cell  clones  exhibited  no 
specific lytic activity on target cells in conventional cytotoxicity assays (unpublished 
results) and lacked the Lyt-2 surface marker (Table I). They can, however, proliferate 
in response to specific antigenic stimulation in the absence of exogenous T  cell growth 
factor  (unpublished  observations).  As  Table  I  demonstrates,  radiolabeled  insulin 
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TABLE  I 
Insulin Binding to T Cell Clones 
Percent dis-  Percent spe- 
CTL line  DaYassayOf,  Lyt p'.enotype:~  placeablecounts§  cific bindingll 
Noncytotoxic T clones 
22-2  3  1  + (76)  2-  70.8 
14-16  3  1-  2-  75 
28-3  3  1  ÷ (48)  2-  81 
M3-2  3  1  + (66)  2-  75 
M3-3  3  1  + (44)  2-  71 
Mls bulk  3  86 
22-2  11  38 
Cytotoxic T clones 
14-1  2  1  + (37)  2  + (23)  5 
14-1  4  1,5 
14-1  10  0,03 
14-7  2  1  ÷ (16)  2  + (68)  0.00 
14-13  4  1  + (50)  2  + (91)  18 
23-9  4  1  + (13)  2  + (72)  0.00 
8.4 
3.8 
8.0 
3.13 
4.46 
8.4 
0.93 
0.19 
0.07 
0.02 
-0.21 
0.12 
-0.04 
* Indicates days post-antigenic stimulation. 
* Numbers in parentheses indicate percent rosette positive cells. 
§ Represents percent of total counts bound displaced by  10  -6 M  insulin. Positive (i.e.,  receptor- 
bearing) cells were required to demonstrate >70%  displaceable counts. 
I[ Represents total counts bound per 10  s viable cells minus nonspecific binding (i.e.,  radioactivity 
bound in presence of 10  -6 M  insulin). 
expression of specific insulin receptors on these activated T  cells. In contrast, a panel 
of H-2-restricted,  influenza  virus-specific  CTL  clones,  stimulated  and  maintained 
under identical conditions, showed only background levels of specific insulin binding 
in  the  standard  ligand  displacement  assay  (Table  I).  The  level  of specific  insulin 
bound by several noncytolytic T  cell clones was comparable to that demonstrated by 
a heterogeneous population of Mls  d locus reactive T  cells from a mixed lymphocyte 
culture [CBA/CaJ (Mls b) responders and irradiated CBA/J (Mls d) stimulators] (Table 
I). 
Table II summarizes studies on the insulin receptor specificity of a representative 
noncytolytic  T  cell clone.  The potency  of various  insulins,  insulin  derivatives,  and 
noninsulin peptides to inhibit porcine xzsI-insulin  binding to the cloned T lymphocytes 
is virtually identical to that seen for IM-9 human lymphoid cells. In previous studies, 
it was shown that IM-9 insulin receptors have specificity for binding that is identical 
to that observed in liver membranes or isolated fat cells (1). 
During  the course of this  study,  representative  cytolytic  and  noncytolytic  T  cell 
clones were examined for insulin receptor expression at various times after antigenic 
stimulation. The cytolytic clone  14-1 showed no specific insulin binding at days 2, 4, 
and 10 after antigenic stimulation  (Table I). In contrast, the noncytolytic clone 22-2, 
which expressed the insulin receptor on day 3 after antigenic stimulation, was negative 
for receptor expression  by  day  11  (Table  I).  In  light  of this  observation,  it  was of 
interest to examine the kinetics of receptor expression on the noncytolytic T cells after 
antigenic  stimulation.  Using  clone  22-2,  we  examined  the  emergence  of  insulin 
receptors,  the incorporation  of [aH]thymidine  as a  measure  of rate of proliferation, 
and viable cell numbers at days 2, 3, 4, and 9 post-antigenic stimulation.  As seen in 
Fig.  1,  resting  T  cells  (day  0)  lack  detectable  insulin  receptors.  After  antigenic 
stimulation,  both  the  expression  of insulin  receptors  (panel  a)  and  [3H]thymidine 
incorporation in the cultures  (panel b) peak on day 3 and decline by day 4. The cell 
numbers (panel c) are still increasing as of day 4 but slowly decline by day 9 because BRACIALE  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
Specificity of T lymphocyte Insulin-binding Receptor 
Preparation 
Potency relative to porcine insulin* 
IM-9 cell  T cell clone 22-2 
Porcine insulin  100  100 
Porcine proinsulin  5.6  10 
Catfish insulin:~  24  15 
Desoctapeptide  insulin  1.3  1.5 
Glucagon  0  0 
Human growth hormone  0  0.14 
* Potency estimates expressed as the molar concentration of porcine insulin required for 
50% inhibition of specific binding/molar concentration of peptide for 50% inhibition of 
binding ×  100. 
:[: Catfish insulin supplied by Dr. M. A. Permutt. (Washington Univ., St. Louis, MO.) 
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DAYS  AFTER 
ANTIGENIC  STIMULATION 
FIo.  1.  Induction of insulin receptor expression (panel a), rate of proliferation  (panel b), and cell 
growth  (panel  c)  for  noncytotoxic  T  cell  clone  22-2.  Clone  22-2  cells  (day  10  post-antigenic 
stimulation) were cultured in the presence of A/Memphis/l/71 influenza-infected, irradiated (2000 
tad)  syngeneic  (CB6FI)  splenic  stimulators  and  medium  with  10%  crude  rat  eoncanavalin  A 
supernatant (day 0). At various days (2,  3, 4, 9), cells were harvested for the insulin radioreeeptor 
assay (panel a), [3H]thymidine incorporation  assay (panel b), or trypan blue exclusion viable cell 
counts (panel c).  Scatchard  analysis of binding data on day 3  revealed a  KA of 5.65  ×  10  s  M -1, 
similar to the insulin receptors of various biologically responsive tissue (14). 
of exhaustion of nutrients in the medium or cell crowding. By day 9 after stimulation, 
both insulin receptor expression  and  [3H]thymidine incorporation return  to back- 
ground levels (500 cpm). It should be noted that the resting T  cells (day 0)  used in 
these analyses were clone 22-2 cells obtained 10 d post-antigenic stimulation. Hence, 
these quiescent T  cells, although insulin receptor negative, are viable and can be 
induced by specific antigenic stimulation to proliferate and concomitantly express 
insulin receptors. 
Discussion 
In  this  report  we  have  examined  a  panel  of murine  T  lymphocyte  clones  with 
different  functional  activities  (cytolytic vs.  noncytolytic)  for the expression of insulin 668  BRACIALE  ET  AL.  BRIEF  DEFINITIVE  REPORT 
receptors. We have previously reported (6) the isolation and characterization of long- 
term H-2-restricted virus-specific CTL clones. By a similar protocol, we have isolated 
noncytotoxic T  cell  clones  that  are  antigen  specific,  and  although  grown  in  the 
presence  of exogenous  T  cell  growth  factor,  do  not  require  it  (12,  unpublished 
observations). Our goals in this report were first, to examine our T  cell clones for 
insulin receptor expression, and second, to correlate insulin receptor expression with 
events after specific antigenic stimulation. 
The noncytotoxic T  cell clones we have examined, which express insulin receptors, 
do so in an inducible fashion. That is, insulin receptors are detectable shortly after 
antigenic stimulation but are absent several days later when the cells are still viable 
but  no  longer  actively proliferating as  measured  by  [aH]thymidine  incorporation. 
These resting cells then readily express insulin receptors again when stimulated by 
specific antigen. 
In  contrast,  the  cytotoxic T  cell clones  that  we  have examined  lack  detectable 
insulin receptors, both shortly after antigenic stimulation  (at the peak of the prolif- 
erative response) and at various times thereafter. This result was somewhat surprising 
in  light of the  finding that  insulin  could augment  the in  vitro activity of in  vivo 
allograft stimulated lymphocytes (13) and data indicating a close relationship between 
cytotoxic T  effectors and insulin receptor-bearing lymphocytes from the same mixed 
lymphocyte culture (5).  It should be emphasized that  the dichotomy between non- 
cytolytic and cytolytic T cell clones in insulin receptor expression cannot be attributed 
to culture conditions, as both the cytotoxic and  noncytotoxic T  cell clones used in 
these experiments were grown in the presence of antigen and exogenous T cell growth 
factor (coneanavalin A supernatant). 
Our results suggest that the insulin receptor is not as universal a marker of T  cell 
activation  as previously thought.  It seems  likely that  there may be discrete T  cell 
subpopulations  in which  insulin  will  have biologic effects, whereas  the equivalent 
effects on other T  cell subpopulations  may well be regulated  by other insulin-like 
peptides. 
We are, therefore, now engaged in investigations on the effects of insulin  on the 
growth  and  function of the cytotoxic vs.  non-cytotoxic T  cell clones.  Also, we  are 
currently  screening  human  cytotoxic  and  noncytotoxic T  cell  clones  for  insulin 
receptor expression. The availability of these homogeneous nontransformed cells with 
functional activity and inducible insulin receptor expression opens up new opportu- 
nities to study the effects of insulin  on the immune system and  also  its  effects on 
lymphocyte cellular function and growth. 
Summary 
This study demonstrates that the insulin receptors are expressed on the surface of 
some T  cell clones after specific antigenic stimulation. The insulin receptors on these 
lymphocytes are physicochemically similar to insulin receptors present on cells which 
express the  receptors constitutively  (adipocytes, hepatocytes, etc.).  The  kinetics  of 
expression of insulin receptors on cloned, noncytotoxic T  cells after specific antigenic 
stimulation closely parallels that of [aH]thymidine incorporation in such cultures. 
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